Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Triazine-based adenosine antagonists in development at Boehringer Ingelheim

April 29, 1999

Sibia identifies novel mGluR5-selective compounds

April 29, 1999

New CRF antagonists described by DuPont for stress-related disorders

April 29, 1999

Continuing focus on PARP inhibitors at Guilford

April 29, 1999

Cypros given notice of allowance on U.S. patent for NCCBs

April 29, 1999

Safety and efficacy of riluzole examined in pilot study in early, untreated PD

April 28, 1999

Guilford's new PARP inhibitors potentially useful for wide variety of disorders

April 28, 1999

Tryptamine analogues as potent and selective human 5-HT2A antagonists

April 28, 1999

Lamotrigine effective in HIV-associated painful sensory polyneuropathy

April 28, 1999

Improvement in spasticity noted with small doses of Zanaflex

April 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...